Senior insider sale
President & CEO at MERSANA THERAPEUTICS, INC. — senior position signals high conviction
$11.6K
17.73K shares
What this filing means
PROTOPAPAS ANNA plans to sell 17.73K shares of MERSANA THERAPEUTICS, INC. valued at approximately $11.6K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 1/16/2025ACC: 0001104659-25-004177
DirectorOfficer· President & CEO
Since Jan 2019
17.73K
Shares to sell
$11.6K
Approx. market value
16.75K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Vesting of restricted stock unit grant
Services rendered
1/14/2025
16.75KTotal acquired16.75K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
1/14/2025 | Vesting of restricted stock unit grant Services rendered | 16.75K | — |
| Total | 16.75K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
11.53K
Market value
$7.6K
1/14/2025
Planned — Approximate Date
NASDAQPlanned
Units to sell
6.19K
Market value
$4.0K
1/15/2025
Total
Units
17.73K
Value
$11.6K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
1/14/2025 | 11.53K | $7.6K | — | Completed |
| Planned — Approximate Date | ||||
1/15/2025 | 6.19K | $4.0K | NASDAQ | Planned |
| Total | 17.73K | $11.6K | ||